The Cooper Companies, Inc.
COO
Classifica tra le azioni
#1896
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Prezzo delle azioni
$58.91
Capitalizzazione di mercato
$11.20B
Variazione (1 giorno)
1.29%
Variazione (1 anno)
-21.45%
Paese
US
Scambia The Cooper Companies, Inc. (COO)
Categoria
Healthcare
Utile per The Cooper Companies, Inc. (COO)
Utile nel Jul 2026 TTM: $462.40M
Secondo gli ultimi rapporti finanziari di The Cooper Companies, Inc., gli utili attuali della società sono $462.40M. Nel 2024, la società ha registrato un utile di $582.30M, un aumento rispetto a agli utili del 2023, che erano di $412.90M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di The Cooper Companies, Inc. dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $462.40M | -18.38% |
| 2025 | $566.50M | -2.71% |
| 2024 | $582.30M | 41.03% |
| 2023 | $412.90M | -13.13% |
| 2022 | $475.30M | -3.30% |
| 2021 | $491.50M | 84.43% |
| 2020 | $266.50M | -44.18% |
| 2019 | $477.40M | 43.84% |
| 2018 | $331.90M | -15.76% |
| 2017 | $394.00M | 33.27% |
| 2016 | $295.63M | 37.19% |
| 2015 | $215.49M | -27.33% |
| 2014 | $296.53M | -5.04% |
| 2013 | $312.27M | 13.37% |
| 2012 | $275.45M | 42.90% |
| 2011 | $192.76M | 54.92% |
| 2010 | $124.43M | 8.36% |
| 2009 | $114.83M | 50.68% |
| 2008 | $76.21M | 11,240.33% |
| 2007 | $672.00K | -99.08% |
| 2006 | $73.34M | -32.38% |
| 2005 | $108.46M | -3.58% |
| 2004 | $112.49M | 24.32% |
| 2003 | $90.49M | 38.85% |
| 2002 | $65.17M | 25.02% |
| 2001 | $52.13M | 23.74% |
| 2000 | $42.13M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $3.81B | 723.05% |
US
|
|
| $4.11B | 788.59% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 243.86% |
US
|
|
| - | - |
CH
|
